Organisation paid for research Program year 2025 Source: CMS Open Payments

USC

Neither a doctor nor a teaching hospital

Research payments

$75,774

4 payments

Through program year 2025, USC is reported as receiving $75,774 in research payments, across 4 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$7,000	1
2024	Research	$2,290	1
2023	Research	$66,484	2

Breakdown

Who paid Research payments · program years 2023–2025

Merck Sharp & Dohme Corporation $53,418 1 payment
E.R. Squibb & Sons, L.L.C. $22,356 3 payments

Studies the money was for Research payments · program years 2023–2025

A Phase I,II Study of Regorafenib and Pembrolizumab in Colorectal Cancer Patients in 3rd and 4th line setting. $53,418 1 payment
Phase I/IIA 2L/3L CRC MSS KRAS Nivo/MEK Combo (trametinib/Novartis) $15,356 2 payments
A Study of Nivolumab in Combination With Trametinib With Or Without Ipilimumab in Participants With Previously Treated Metastatic Colorectal Cancers $7,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.